SCHEMBL10808531

SCHEMBL10808531

CCCCCCCCCCCCCCc1cccc(OCC(COP(O)OCCCC[N+](C)(C)C)OC(C)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 6/20 0.45
▸ PPARG P37231 4/20 0.45
▸ CNR1 P21554 2/20 0.42
▸ CNR2 P34972 2/20 0.42
▸ CYP2D6 P10635 2/20 0.40
▸ CHRM2 P08172 2/20 0.39
▸ CHRM1 P11229 2/20 0.39
▸ CHRM3 P20309 2/20 0.39
▸ ADRA1D P25100 1/20 0.38
▸ PTAFR P25105 1/20 0.38
▸ HTR1D P28221 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ ADRA1B P35368 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ TMEM97 Q5BJF2 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10805747 1.00 PPARA (0.45) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10808654 0.97 PPARA (0.46) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10811983 0.97 PPARA (0.46) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10804840 0.95 PPARA (0.47) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10806823 0.95 PPARA (0.47) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10809134 0.90 PPARA (0.46) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10810983 0.90 PPARA (0.46) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10807129 0.89 ADRA1D (0.41) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL10810295 0.88 PPARA (0.45) PPARAPPARGCNR1CNR2CYP2D6
SCHEMBL10810264 0.88 PPARA (0.45) PPARAPPARGCNR1CNR2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4640913-A Phosphocholine derivatives having antihypertensive action AMERICAN CYANAMID COMPANY (US) 1987-02-03 — — US disclosed
Send feedback